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goes, as a consequence of placental lactogens and prolactin
(PRL) action, functional changes that are characterized by
increased glucose-induced insulin secretion. After delivery,
the maternal endocrine pancreas rapidly returns to non-
pregnant state, which is mainly attributed to the increased
serum levels of glucocorticoids (GCs). Although GCs are
known to decrease insulin secretion and counteract PRL
action, the mechanisms for these effects are poorly under-
stood.We have previously demonstrated that signal transducer
and activator of transcription 3 (STAT3) is increased in islets
treated with PRL. In the present study, we show that STAT3
expression and serine phosphorylation are increased in
pancreatic islets at the end of pregnancy (P19). STAT3 serine
phosphorylation rapidly returned to basal levels 3 days after
delivery (L3). The expression of the sarcoendoplasmicJournal of Endocrinology (2007) 195, 17–27
0022–0795/07/0195–017 q 2007 Society for Endocrinology Printed in Greatreticulum Ca2C-ATPase 2 (SERCA2), a crucial protein
involved in the regulation of calcium handling in b-cells, was
also increased in P19, returning to basal levels at L3. PRL
increased SERCA2 and STAT3 expressions and STAT3
serine phosphorylation in RINm5F cells. The upregulation
of SERCA2 by PRL was abolished after STAT3 knockdown.
Moreover, PRL-induced STAT3 serine phosphorylation and
SERCA2 expression were inhibited by dexamethasone
(DEX). Insulin secretion from islets of P19 rats pre-incubated
with thapsigargin and L3 rats showed a dramatic suppression
of first phase of insulin release. The present results indicate
that PRL regulates SERCA2 expression by a STAT3-
dependent mechanism. PRL effect is counteracted by DEX
and might contribute to the adaptation of maternal endocrine
pancreas during the peripartum period.
Journal of Endocrinology (2007) 195, 17–27Introduction
In pancreatic b-cells, the most prominent effect attributed to
Janus kinase/signal transducer and activator of transcription 5
(JAK/STAT5) signaling pathway is the functional adaptation
induced by placental lactogens (PL) and prolactin (PRL) during
pregnancy (Brelje et al. 1993, Nielsen et al. 1999). The biological
effects exertedbyPRL in theendocrinepancreas are characterized
by a marked increase in pancreatic b-cell proliferation and
sensitivity to glucose, together with a decrease in apoptosis
(Parsons et al. 1992, Scaglia et al. 1997, Bonner-Weir 2001).
The elevated concentration of glucocorticoids (GCs) found
during the late stage of pregnancy is believed to counteract the
PRL-induced adaptation of endocrine pancreas, reestablishing
the non-pregnant phenotype in pancreatic b-cells. It has beendemonstrated that dexamethasone (DEX), a synthetic
glucocorticoid, reverses PRL-induced upregulation of islet
function by inhibiting glucose metabolism (Shao et al. 2004),
PDX-1 expression (Nasir et al. 2005), insulin secretion, and cell
proliferation, and by increasing apoptosis (Weinhaus et al. 2000).
Curiously, GCs have been reported to strongly synergize with
PRL-induced STAT5 activation through distinct mechanisms
involving the glucocorticoid receptor (Stocklin et al. 1996,
Lechner et al. 1997, Wyszomierski et al. 1999). Therefore, a
distinct mechanism activated by PRL, other than the activation
of the JAK2/STAT5 pathway, is likely to be negatively
modulated by GCs in pancreatic b-cells.
It is well known that the exocytosis of insulin-containing
granules is tightly regulated by changes in cytosolic Ca2C
concentration. A disturbance in the Ca2C sequestration byDOI: 10.1677/JOE-07-0010
Britain Online version via http://www.endocrinology-journals.org
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sarcoER Ca2C-ATPase (SERCA) activity and expression, has
been suggested as the cause of impaired insulin secretion in
several animal models of glucose intolerance (Marie et al.
2001, Kulkarni et al. 2004), including the db/db mice (Roe
et al. 1994). db/db Mice display obesity and type 2 diabetes,
due to the absence of functional leptin receptors, the main
activator of STAT3 in pancreatic b-cells (Shafrir 1992,
Morton et al. 1999). We have demonstrated that adult
pancreatic islets, cultured with PRL, show an upregulation in
STAT3 gene expression (Bordin et al. 2004). It is noteworthy
that STAT3 knockout mice develop abnormal islet archi-
tecture and an impairment in the early phase of glucose-
induced insulin secretion (Gorogawa et al. 2004) and glucose
intolerance (Cui et al. 2004).
In the present study, we aimed to investigate whether the
expression and phosphorylation status of STAT3 in pancreatic
islets of pregnant and lactating rats correlates with the
SERCA isoforms expression and, thus, with the insulin
secretion pattern. We found that PRL induces SERCA2
expression in pancreatic b-cells through a STAT3-mediated
mechanism. Additionally, we show that this phenomenon is
inhibited by DEX.Materials and Methods
Materials
General chemical reagents were obtained from Synth
(Diadema, SP, Brazil). RPMI-1640 medium, trypsin, and
fetal bovine serum (FBS) were from Cultilab (Campinas, SP,
Brazil). BSA (fraction V), collagenase type V, Tris, dithio-
threitol, luminol, p-coumaric acid, and thapsigargin were
from Sigma. Rat PRL was purchased from Dr A F Parlow
(Harbor University of California Los Angeles Medical
Center, USA). DEX disodium phosphate was from Labor-
ato´rios Ache´ (Sa˜o Paulo, SP, Brazil). The apparatus for SDS-
PAGE was from Bio-Rad. The nitrocellulose membranes
were purchased from Bioagency (Sa˜o Paulo, SP, Brazil).
Antibodies against STAT3 (sc483), STAT5 (sc835), pSTAT3-
Tyr (sc8059), SERCA2 (sc8095), SERCA3 (sc8097),
a-tubulin (sc-8035), and HRP-conjugated and anti-goat
were from Santa Cruz Technology (Santa Cruz, CA, USA).
The antibody against pSTAT3-Ser (9134) was from Cell
Signaling (Danvers, MA, USA). [125I]Insulin, HRP-con-
jugated anti-rabbit and anti-mouse antibodies were from
Amersham-Pharmacia Biotech. X-ray sensitive films and
chemicals were from IBF (Rio de Janeiro, RJ, Brazil). GoTaq
DNA polymerase and ImProm-II reverse transcriptase were
from Promega. PCR primers and phosphorothioate
scrambled and antisense oligonucleotides were from IDT
(Integrated DNA Technologies, Coralville, IA, USA). Opti-
MEM, random primers, dNTP set, agarose, Trizol reagent,
antibiotics, antimycotic, and Lipofectamine 2000 were fromJournal of Endocrinology (2007) 195, 17–27Invitrogen. All plastics for cell culture were from TPP
(Trasadingen, Switzerland).Animals and islet isolation
Two female rats and one male rat were housed together for
5 days. The presence of spermatozoa in the vaginal wash
indicated day 0 of gestation. Immediately after delivery, the
number of pups was adjusted to eight for each lactating
mother. Pregnant and lactating rats were killed at 19 days
post-coitus (P19) and 3 and 8 days post partum (L3 and L8
respectively). Virgin age-matched rats were used as the
control group (CTL). Islets were isolated by collagenase
digestion, as previously described (Bordin et al. 1995). All of
the experiments involving animals were in accordance with
the guidelines of the Brazilian College for Animal
Experimentation.Insulin secretion
Cumulative insulin secretion was performed in pancreatic
islets from female virgin rats after a 36-h culture. Previously to
the culture, groups of 300 islets were transfected with
antisense oligonucleotide (ASO) against STAT3 or treated
only with Lipofectamine 2000. After culture, groups of five
islets were first incubated for 30 min at 37 8C in Krebs-
bicarbonate buffer containing 5.6 mM glucose and equili-
brated with 95% O2/5% CO2 (pH 7.4). The solution was
then replaced by fresh Krebs-bicarbonate buffer and the islets
were incubated for a further 60-min period with medium
containing 2.8 or 16.7 mM glucose. After the incubation
period, the supernatant was kept for insulin determination.
Insulin secretion in dynamic conditions was performed, as
previously described (Bosqueiro et al. 2000). Briefly, groups
of 20 islets were isolated from CTL, P19, and L3 rats,
transferred to chambers, and perfused for 30 min with Krebs-
bicarbonate containing 2.8 mM glucose. A group of islets
isolated from P19 rats was also pre-incubated with 5 mM
thapsigargin for 20 min before the beginning of perfusion.
The medium was then changed to Krebs-bicarbonate
containing 16.7 mM glucose and the islets were perfused
for an additional 30 min. The effluent was collected every
1 min from the min 20 until the end of the perfusion period.
Since islets from P19 rats are usually larger than CTL and L3
islets, dynamic insulin secretion are expressed relative to
insulin content. For this, the islets were sonicated in lysis
buffer (70% ethanol and 0.2 M HCl) and incubated overnight
at 4 8C. The insulin content of each sample was measured by
RIA using rat insulin as a standard.RINm5F cells and isolated islets culture, treatment, and
transfection
Islets and RINm5F cells were cultured in RPMI-1640
medium containing 11 mM glucose, 10% FBS, and penicillin
and streptomycin in a humidified atmosphere with 5% CO2 atwww.endocrinology-journals.org
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500 ng/ml and 100 nM respectively. PRL was added to the
medium 6 h prior to DEX. RINm5F cell treatment was
carried out in serum-free medium containing 1% BSA, and
islets in medium containing 10% FBS; 24 h after treatment,
cells were used to western blot and islets for RNA extraction.
For transfection,Opti-MEMcontaining 10 mMglucose plus a
chimeric DNA–RNA 2 0-O-methyl phosphorothioate oligo-
nucleotide, previously mixed with Lipofectamine 2000, was
added to RINm5F cells and isolated islets. CTL cells and islets
were treated only with Lipofectamine. The oligonucleotides
used for transfectionwere a scrambled oligonucleotide (S)with
no effect on STAT3 expression, and an antisense oligonucleo-
tide targeted to STAT3 (ASO). After 4 h, the medium was
supplemented with RPMI containing 1% BSA with or
without PRL. After 24 h, total protein was extracted and
processed for western blotting. The sequences of the S
and ASO oligonucleotides were 5 0-GmCmUmGCTG-
GAGCTGGmUmUmCmC-3 0, and 5 0-mGmCmAmC-
GATCGATCCCmCmAmUmG-3 0 respectively where ‘m’
denotes RNA 2 0-O-methyl nucleotides.RT-PCR analysis
Total RNAwas extracted from 24-h cultured islets using Trizol
reagent.RT-PCRwasperformedas previously described (Bordin
et al. 2004). The primer sets used in RT-PCR analysis, with their
respective melting temperatures and product lengths, were:
GLUT2: 50-CATTGCTGGAAGAAGCGTATCAG-30 and
50-GAGACCTTCTGCTCAGTCGACG-30, 55 8C, 408 bp;
SUR1: 5 0-TTCCACATCCTGGTCACACCG-3 0 and
50-AGAAGGAGCGAGGACTTGCCAC-30, 60 8C, 425 bp;
SERCA2: 50-CTCTGGGTCAATCTGGTGACGG-30 and
5 0-TGCCATTGTCATCGGATACGG-3 0, 58 8C, 324 bp;
and RPL37a: 50-CAAGAAGGTCGGGATCGTCG-30 and
50-ACCAGGCAAGTCTCAGGAGGTG-30, 57 8C, 290 bp.
The RNAs used for RT-PCR analysis were obtained from
three or four independent experiments.Western blot analysis
Freshly isolated pancreatic islets and RINm5F cells were
homogenized in 100 ml of solubilization buffer and processed
for protein extraction and western blot, as previously described
(Anheˆ et al.2006).Before incubationwith the primary antibody,
the membranes were blocked with blocking buffer (5% nonfat
dried milk, 10 mMTris, 150 mMNaCl, and 0.02% Tween 20)
for 2 h at 22 8C. The membranes were incubated for 4 h at
22 8Cwith the primary antibody diluted in blocking bufferwith
3% nonfat dried milk. After being washed for 30 min in
blocking buffer without milk, the membranes were incubated
with peroxidase-conjugated secondary antibody for 1 h, and
processed for chemiluminescence to visualize the immuno-
reactive bands. Quantitative analysis of the blots was performed
by Scion Image software.When the primary antibodywas a goatwww.endocrinology-journals.orgpolyclonal, nonfat dried milk was replaced by 1% gelatin in all
incubations.Statistical analysis
The results were expressed as the meanGS.E.M. The results
were compared using ANOVA followed by the Tukey–
Kramer test or Student’s unpaired t-test. P values !0.05
indicated a significant difference.Results
STAT3 expression and phosphorylation in pancreatic islets
during pregnancy and lactation
Our results show that the protein content of STAT3 is
increased in pancreatic islets at the end of the gestational
period (1.5-fold for P19 compared with CTL; P!0.05). This
increase persisted until day 3 of lactation (1.4-fold for L3
compared with CTL; P!0.05) returning to control values on
day 8 (L8; Fig. 1A). Tyrosine phosphorylation of STAT3 was
not altered throughout the referred periods (Fig. 1B). STAT3
serine phosphorylation was increased in pancreatic islets from
late pregnant rats (2.1-fold for P19 compared with CTL;
P!0.05). The higher levels of STAT3 serine phosphorylation
were temporally limited to pregnancy and returned to CTL
values in L3 rats (Fig. 1C).Dynamic insulin secretion by pancreatic islets from pregnant and
lactating rats
In islets from pregnant and virgin rats, the introduction of
16.7 mM glucose in the perfusion medium induced a biphasic
insulin secretory response characterized by a prominent and
transient release (first phase) followed by a secondary rise
(Fig. 2). As expected, overall secretion from pregnant rat islets
during the stimulatory period was higher than that of the
control. After parturition, total insulin secretion, measured
over the stimulatory period (31–60 min), returned to values
found in non-pregnant rat islets. However, the first-phase
release from islets from lactating rats at L3 was abolished
(P!0.05 compared with CTL and P19).SERCA2 and SERCA3 expressions in pancreatic islets during
pregnancy and lactation and participation of SERCA in the
insulin secretion during pregnancy
The protein content of SERCA3 was similar in pancreatic
islets from P19, L3, and CTL (Fig. 3A). However, SERCA2
was significantly increased in pancreatic islets from P19 rats,
returning to CTL values in L3 rats (2.7-fold for P19
compared with CTL; P!0.05; Fig. 3B). In order to clarify
the role of this SERCA2 in the dynamic feature of insulin
secretion during pregnancy, we treated pancreatic islets from
P19 rats with thapsigargin, an irreversible SERCA inhibitor.Journal of Endocrinology (2007) 195, 17–27
Figure 1 STAT3 expression, serine, and tyrosine phosphorylation in
pancreatic islets from pregnant and lactating rats. Pancreatic islets
were isolated from pregnant (P19) and lactating (L3 and L8) rats.
Protein extracts were processed for western blotting for STAT3 (A;
nZ5), pSTAT3-Tyr (B; nZ5) and pSTAT3-Ser (C; nZ8). The bars
represent the meansGS.E.M. of the values determined by optical
densitometry. *P!0.05 versus CTL.
Figure 2 Dynamic insulin secretion by pancreatic islets from
pregnant and lactating rats. Groups of 20 islets were isolated from
CTL, P19, and L3 rats, transferred to chambers, and perfused with
Krebs-bicarbonate containing 2.8 mM glucose for the initial
30 min. The medium was replaced by a solution containing
16.7 mM glucose for an additional 30 min of perfusion. The dotted
line represents insulin secretion from CTL rat islets. Continuous
lines with open and black circles represent insulin secretion from
P19 and L3 rat islets respectively. Mean values (GS.E.M.) refer to four
individual experiments. *P!0.05 versus CTL.
G F ANHEˆ and others . STAT3-regulated SERCA2 expression by prolactin20Figure 3C shows that pharmacological blockade of SERCA
in pancreatic islets from P19 rats resulted in a significant
reduction of the first phase of insulin secretion (P!0.05). In
contrast, the secondary rise in insulin secretion from P19 islets
treated with thapsigargin showed a tendency to be higher
than P19 islets that were pre-incubated only with glucose.Journal of Endocrinology (2007) 195, 17–27Specificity and efficiency of the phosphorothioate antisense
oligonucleotide targeted to STAT3
Western blot analysis in RINm5F cells transfected with
antisense phosphorothioate oligonucleotide targeted to
STAT3 (ASO) revealed that this oligo efficiently reduces
STAT3 protein content without any interference in STAT5
and a-tubulin expressions. Additionally, the effect of ASO is
not due to a non-specific effect, since the transfection with
the scrambled control oligo (S) did not cause any disruption in
STAT3 expression (Fig. 4A). As observed in pancreatic islets
from STAT3-knockout mice (Gorogawa et al. 2004), GLUT2
(0.63-fold for ASO compared with CTL; P!0.05) and
SUR1 (0.60-fold for ASO compared with CTL; P!0.05)
mRNA expressions were decreased in RINm5F cells
transfected with ASO (Fig. 4B and C respectively).
RINm5F cells treated with PRL for 24 h displayed an
increase in STAT3 protein content (1.9-fold compared with
CTL; P!0.05). Transfection with ASO reduced STAT3
content (0.38-fold compared with CTL; P!0.05) and
abolished the PRL-induced increase in STAT3 (Fig. 4D).Modulation of SERCA2, but not SERCA3, by PRL in
RINm5F cells and the participation of STAT3
Figure 5A shows that PRL induced an increase in the SERCA2
content of RINm5F cells (1.59-fold compared with CTL;
P!0.05), while transfection with ASO reduced the SERCA2www.endocrinology-journals.org
Figure 3 Participation of SERCA in insulin secretion during pregnancy and its expression in pancreatic islets
from pregnant and lactating rats. Pancreatic islets were isolated from pregnant (P19) and lactating (L3 and L8)
rats. Protein extracts were processed for western blot detection of SERCA3 (A; nZ3) and SERCA2 (B; nZ4).
Groups of 20 islets were isolated from P19 rats and pre-incubated with (P19CTG) or without (P19) 5 mM
thapsigargin for 20 min before the beginning of perfusion. After this period, the islets were transferred to
chambers and perfused with Krebs-bicarbonate containing 2.8 mM glucose for the initial 30 min. The
medium was replaced by a solution containing 16.7 mM glucose for an additional 30 min of perfusion. Open
circles represent P19 islets and black triangles represent P19 islets pre-incubated with TG (C; nZ4). The bars
and the lines represent the meansGS.E.M. of the values. *P!0.05 versus CTL; #P!0.05 versus P19 in the
absence of TG.
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upregulation of SERCA2 was not observed in RINm5F cells
treatedwith PRL and previously transfectedwithASO targeted
to STAT3. The effect of PRL onRINm5F cells was specific for
SERCA2 since no differences were found in SERCA3
expression (Fig. 5B). Figure 5C shows that the knockdown of
STAT3 expression prompts an increase in the 1-h cumulative
insulin secretion induced by glucose (P!0.05 versus CTL islets
with 16.7 mM glucose), without any effect on the basal
(2.8 mM glucose) insulin secretion.Combined effect of DEX and PRL on STAT3 expression and
phosphorylation in RINm5F cells
Figure 6A shows that PRL alone or in combination with
DEX promoted a similar increase in the STAT3 content in
RINm5F cells (1.95-fold for PRL and 2.00-fold for DEXC
PRL when compared with CTL; P!0.05). DEX alone did
not alter STAT3 expression in RINm5F cells. Tyrosine
phosphorylation of STAT3 was not altered by PRL, DEX, or
the combination of both agents (Fig. 6B).www.endocrinology-journals.orgSTAT3 serine phosphorylation was increased in RINm5F
cells treated with PRL (1.30-fold compared with CTL;
P!0.05). DEX alone, or in combination with PRL, reduced
the levels of STAT3 serine phosphorylation (0.60-fold for
DEX and DEXCPRL compared with CTL; P!0.05;
Fig. 6C).Combined effect of DEX and PRL on SERCA2 protein and
mRNA expression in RINm5F cells and cultured rat pancreatic
islets
Figure 7A shows that PRL-induced SERCA2 expression in
RINm5F cells was abolished by the presence of DEX.
Additionally, DEX alone promoted a reduction in SERCA2
content in RINm5F cells (0.75-fold compared with CTL;
P!0.05). Figure 7B shows that PRL also induced an increase
in SERCA2 mRNA in cultured rat pancreatic islets (1.20-
fold compared with CTL; P!0.05). This effect was also
counteracted by the addition of DEX to the culture medium
and, in this case, DEX alone did not reduce SERCA2
expression (Fig. 7B).Journal of Endocrinology (2007) 195, 17–27
Figure 4 STAT3 knockdown in RINm5F cells treated with prolactin.
RINm5F cells were transfected with a phosphorothioate oligonu-
cleotide targeted to STAT3 (ASO) and with a scrambled oligonu-
cleotide with no effect on STAT3 expression (S). CTL cells were
treated only with the Lipofectamine. After 24 h from the
transfection, the cells were processed for western blot detection of
STAT3, STAT5, and a-tubulin (A) and for RT-PCR of GLUT2 (B; nZ7)
and SUR1 (C; nZ5) genes. After the transfection, a distinct group of
cells (ASO and CTL), were transferred to a 1% BSA medium in the
presence or in the absence of PRL. After 24 h, the cells were
processed for western blot detection of STAT3 (D; nZ7). The bars
represent the meansGS.E.M. of the values determined by optical
densitometry. *P!0.05 versus CTL; #P!0.05 versus PRL and
&P!0.05 versus ASO.
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We have previously demonstrated that in vitro treatment of
pancreatic islets with PRL increases STAT3 expression
(Bordin et al. 2004). Attempting to investigate the partici-
pation of STAT3 in a physiological situation in which the
high levels of PRL are determinant for the adaptation of the
endocrine pancreas, we first examined STAT3 expression andJournal of Endocrinology (2007) 195, 17–27phosphorylation status in islets from pregnant and lactating
rats. STAT3 expression was increased in pancreatic islets from
P19 and L3 rats. Since PRL serum levels remain high during
the transition from late pregnancy to early lactation (Kawai &
Kishi 1999), it is reasonable to assume that modulation of
STAT3 expression during the peripartum period may be due
to PRL action. We also found that serine, but not tyrosine
basal phosphorylation of STAT3, is increased in the pancreatic
islets of late pregnant rats. Thus, the current study aimed to
clarify the putative participation of STAT3 and its serine
phosphorylation in the physiology of pancreatic islets during
pregnancy.
The increase in STAT3 serine phosphorylation was also
detected in RINm5F cells treated with PRL. Taken together,
the in vivo and in vitro data of the present study strongly
indicate that PRL may modulate not only STAT3 expression,
but also its serine phosphorylation. In accordance to our
results, Neilson and collaborators have recently shown that
PRL induces direct activation of STAT3 after a 24-h
treatment (Neilson et al. 2007). Interestingly, insulin has also
been reported to stimulate STAT3 serine phosphorylation
(Ceresa & Pessin 1996). PRL increases insulin secretion from
isolated pancreatic islets (Sorenson et al. 1993, Crepaldi et al.
1997), and high serum insulin levels present in late pregnancy
return to normal levels on day 1 after delivery (Kawai & Kishi
1999). Thus, the hypothesis that PRL increases STAT3 serine
phosphorylation indirectly through the modulation of insulin
secretion must also be considered to explain the results
showed herein.
Although it is classically recognized that tyrosine phos-
phorylation of STAT3 is a prerequisite for the activation of
gene transcription (Aaronson & Horvath 2002), the role of
serine phosphorylation in the regulation of STAT3 activity
remains controversial. Recent evidence suggests that STAT3
serine phosphorylation, which occurs within a mitogen
activated protein kinase (MAPK) consensus site (Ser727), has
a positive role in STAT3 transcriptional activation (Shen et al.
2004, Kojima et al. 2005, Sun et al. 2006). Indeed,
extracellular signal-regulated protein kinases (ERKs) acti-
vation targets STAT3 serine phosphorylation (Kuroki &
O’Flaherty 1999, O’Rourke & Shepherd 2002). We have
previously demonstrated that PRL activates ERK1/2 in vitro
in isolated islets (Amaral et al. 2003) and in vivo in islets from
pregnant rats (Amaral et al. 2004). Therefore, we may
speculate that PRL may target STAT3 serine phosphorylation
in pancreatic islets by activation of ERK1/2. This can occur
by a direct action of PRL or as the consequence of the
increased insulin circulating levels, since insulin-induced
STAT3 serine phosphorylation is ERK1/2 dependent (Ceresa
et al. 1997).
The dynamics of insulin secretion by pancreatic islets from
pregnant rats showed that, during pregnancy, there is a
marked increase in glucose response. This result is in
accordance with classical studies that report an increased
insulin secretion from late pregnant rats (Green & Taylor
1972, Lipson & Sharp 1978). The upregulation of both thewww.endocrinology-journals.org
Figure 5 Effect of PRL and STAT3 knockdown on SERCA2 and SERCA3 expressions in RINm5F cells and
insulin secretion in isolated pancreatic islets. CTL RINm5F cells and ASO transfected cells were transferred to
a 1% BSA medium in the presence or absence of PRL. After 24 h, the cells were processed for western blot
detection of SERCA2 (A; nZ5). Cells treated with PRL were also processed for western blot detection of
SERCA3 (B; nZ3). Groups of 300 pancreatic islets from virgin female rats were cultured overnight and
transiently transfected with antisense oligonucleotide against STAT3 (ASO). CTL islets were treated only with
Lipofectamine 2000. After 36 h of culture, islets were used for insulin secretion assay (C; nZ12). The results
represent the relative expressions of SERCA2 and SERCA3 as determined by optical densitometry, and the 1-h
cumulative insulin secretion by RIE. Data are presented as meanGS.E.M.*P!0.05 versus CTL; #P!0.05 versus
PRL; @P!0.05 versus glucose 2.8 mM within the same condition; &P!0.05 versus CTL in the presence of
glucose 16.7 mM.
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lactating rats. Indeed, the first phase was almost abolished after
parturition. Whilst it has been previously reported that the
insulin secretory response to glucose returns to control values
during early lactation (Hubinont et al. 1986, Kawai & Kishi
1999), the dynamic insulin secretion pattern has not beenwww.endocrinology-journals.orgdemonstrated. The return of the secretory response to a
non-pregnant state is believed to occur due to a decrease in
the rapid exchangeable islet calcium pool (Hubinont et al.
1986, Hubinont & Malaisse 1987). The increase in SERCA2,
but not SERCA3, in islets from pregnant rats and its
immediate reduction on day 3 of lactation might be aJournal of Endocrinology (2007) 195, 17–27
Figure 6 Effect of DEX and PRL on STAT3 expression, and serine
and tyrosine phosphorylation in RINm5F cells. RINm5F cells were
treated with PRL and DEX alone or combined (PRLCDEX) for 24 h.
After the treatment, cells were processed for protein extraction and
western blot detection of STAT3 (A), pSTAT3-Tyr (B), and pSTAT3-
Ser (C). The bars represent the meansGS.E.M. of the values
determined by optical densitometry. *P!0.05 versus CTL;
#P!0.05 versus PRL; nZ7.
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Journal of Endocrinology (2007) 195, 17–27mechanism by which the reduction in intracellular calcium
occurs in islets from lactating rats. This hypothesis is
reinforced here by the significant decrease in the first phase
of insulin secretion in pancreatic islets of P19 rats after the
pharmacological inhibition of SERCA. Therefore, our results
corroborate the former postulation of Hubinont & Malaisse
(1987) that a depletion of endogenous calcium stores
accounts, at least in part, for the decreased insulin secretory
responsiveness to glucose in lactation. Additionally, our results
suggest that calcium stores in pancreatic islets from pregnant
rats, which might result from increased SERCA2 content,
also play a role in the upregulation of the first phase of insulin
secretion during late pregnancy.
Gorogawa et al. (2004) have shown that the disruption of
the STAT3 gene in b-cells (STAT3-insKO mice) resulted in
an impairment of the first phase of glucose-stimulated insulin
secretion. It is well known that Ca2C handling in pancreatic
b-cells plays an important role in the regulation of insulin
secretion. Diminished SERCA expression and activity has
been described as a common dysfunction related to the poor
insulin secretion observed in animal models of diabetes (RoeFigure 7 Effect of DEX and PRL on SERCA2 expression in RINm5F
cells and pancreatic islets. RINm5F cells and islets were treated
with PRL and DEX alone or combined (PRLCDEX) for 24 h. After
the treatment, RINm5F cells were processed for protein extraction
and western blot detection of SERCA2 (A), and pancreatic islets
were processed for total RNA extraction and RT-PCR analysis of
SERCA2 mRNA using RPL37a as housekeeping gene (B). The bars
represent the meansGS.E.M. of the values determined by optical
densitometry. *P!0.05 versus CTL; #P!0.05 versus PRL; nZ4.
www.endocrinology-journals.org
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2001, Kulkarni et al. 2004). Although both SERCA2 and
SERCA3 isoforms are co-expressed in human and rat islets
and in the RINm5F b-cell line (Varadi et al. 1996), several
studies have suggested a central role for SERCA3 in b-cell
function. The absence of SERCA3, however, is insufficient to
alter glucose homeostasis or impair insulin secretion
(Arredouani et al. 2002a). Moreover, SERCA2 instead of
SERCA3 is involved in resting [Ca2C]i regulation in b-cells,
which implicates SERCA2 as the primary SERCA in
physiological conditions (Varadi & Rutter 2002). Corrobor-
ating our data, Crepin et al. (2007) have recently demon-
strated that the expression of SERCA2 is upregulated by PRL
in immortalized epithelial prostatic cells.
In order to investigate whether this marked and reciprocal
temporal pattern of STAT3 serine phosphorylation and
SERCA2 expression observed in vivo was directly correlated
to PRL effects on b-cell, we examined SERCA2 expression
in the b-cell lineage, RINm5F, treated with PRL after the
knockdown of STAT3 gene expression. Similarly to the study
of Crepin et al. (2007), PRL also stimulated SERCA2
expression in RINm5F cells. STAT3 knockdown diminished
SERCA2 expression in RINm5F cell and abolished PRL-
induced SERCA2 expression, indicating that SERCA2 is
regulated by STAT3. Additionally, PRL had no effect on
SERCA3 expression. Our results also show that the knock-
down of STAT3 expression induces, rather than inhibits, a
significant increase in cumulative insulin secretion from
pancreatic islets. This effect is in accordance with the dynamic
insulin secretion of P19 islets treated with thapsigargin. The
pharmacological blockage of SERCA induces a significant
decrease in the first phase of insulin secretion but promoted a
tendency to increase the second phase, which might result in
an overall increase in the cumulative insulin secretion.
Although apparently contradictory, these results agree with
several reports showing that SERCA pump inhibition results
in an increase in the amplitude of the glucose-triggered
Ca2C transients, membrane depolarization, and insulin
exocytosis (Arrredouani et al. 2002a,b, Cruz-Cruz et al.
2005, Beauvois et al. 2006, Hughes et al. 2006). Moreover, in
islets isolated from mice deficient in SERCA3 (the isoform
predominantly expressed in mouse pancreatic b-cells), the
glucose-stimulated insulin secretion is greater than those
from the wild type (Arredouani et al. 2002a). Thus, we
suggest that knockdown of STAT3, and by extension
SERCA2, would decrease the first phase of insulin secretion
(which corresponds to w2% of total amount of insulin
secreted granules) and increase the second phase
(corresponding to 98% of the total granules secreted). The
overall response of this effect can be detected as an increase
in cumulative insulin secretion during a 1-h assay.
In this way, we suggest that the STAT3-mediated SERCA2
expression, showed in the present study, is a mechanism by
which PRL may contribute to the increased glucose-induced
first phase of insulin secretion during pregnancy. Additionally,
these data corroborate previous findings that have correlatedwww.endocrinology-journals.orgthe loss of the secretory response in db/dbmicewith decreased
SERCA activity (Roe et al. 1994). Importantly, the recoveryof
the secretory response in Zucker diabetic fatty rats (ZDF) by
overexpression of functional leptin receptors occurs simul-
taneously to a striking increase in the STAT3 phosphorylation
status (Wang et al. 1998).
The understanding of the mechanisms that regulate the
early phase of glucose-induced insulin secretion is particularly
relevant because subjects with type 2 diabetes show a defective
dynamic of insulin release due to a preferential reduction on
first-phase insulin secretion (reviewed by Ahre´n 2005). The
impairment of the first phase of insulin release frequently
found in diabetic patients extends the duration of postprandial
hyperglycemia and, as a consequence, stimulates a compensa-
tory late-phase hyperinsulinemia (Caumo & Luzi 2004).
Anatomically, the liver is the main target for first-phase insulin
secretion. As the secreted insulin reaches the circulation
through the portal system, a greater hepatic than peripheral
insulinization is rapidly achieved (the so-called porto-
systemic gradient). Thus, according to this hypothesis, the
first phase of insulin secretion is an immediate event that
prompts a significant suppression of hepatic glucose pro-
duction (Luzi & DeFronzo 1989).
Whilst PRL promotes a gain-of-function in islets during
pregnancy, at the end of the gestational period islets undergo a
return to the normal non-pregnant function. The increased
maternal GCs, a characteristic of the late stage of gestation,
have been suggested to contribute to reduced glucose-
stimulated insulin secretion, probably by counteracting the
effect of PRL (Weinhaus et al. 2000, Shao et al. 2004). The
striking correlation between STAT3 serine phosphorylation
and SERCA 2 expression during the peripartum period and
the fact that these alterations are likely to be the result of PRL
action in pancreatic b-cells prompted us to investigate
whether GCs could counteract this effect. The present results
show that DEX abolished PRL-induced upregulation of
STAT3 serine phosphorylation without affecting STAT3
expression. This effect was accompanied by the abolishment
of the upregulation of SERCA2 expression by PRL, in both
RINm5F cells and cultured pancreatic islets. Therefore, the
negative modulation of the PRL-induced augmentation in
STAT3 serine phosphorylation and SERCA2 expression
might participate in the ability of GCs to counteract the
biological effects of PRL in pancreatic islets. In agreement
with this proposition, it was recently described that the pre-
treatment with DEX reduces the first and the second phases of
insulin secretion by rat islets perfused with glucose 15 mM
(Zawalich et al. 2006). Therefore, we speculate that the
downregulation of STAT3-mediated SERCA2 expression by
GC might account for its ability to suppress the first phase of
insulin release. The effect of GC in reducing the second phase
of insulin secretion, as observed in islets from L3 rats, is
probably due to a distinct mechanism.
In summary, the present study shows that STAT3
expression and serine phosphorylation are increased in
pancreatic islets from pregnant rats. These events are probablyJournal of Endocrinology (2007) 195, 17–27
G F ANHEˆ and others . STAT3-regulated SERCA2 expression by prolactin26due to the action of PRL and may therefore upregulate
SERCA2 expression, contributing to the increased pancreatic
b-cell response to glucose, particularly modulating the first
phase of insulin secretion. Moreover, PRL-induced STAT3
serine phosphorylation and SERCA2 expression are counter-
acted by GCs, suggesting an intracellular mechanism by
which insulin secretion returns to normal after delivery.Acknowledgements
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